The PANSAID randomized clinical trial: A pre-planned 1-year follow-up regarding harm.

Kasper Højgaard ThyboDaniel Hägi-PedersenJorn WetterslevSøren OvergaardOle Mathiesen

Published in: Acta anaesthesiologica Scandinavica (2020)

We found no statistically significant difference in 1-year serious adverse events between patients randomized to ibuprofen compared with paracetamol in patients having planned primary total hip arthroplasty. There were few additional events from the 90-day follow-up to the 1-year follow-up.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
peritoneal dialysis
prognostic factors
double blind
total hip arthroplasty
randomized controlled trial
open label
study protocol